193 related articles for article (PubMed ID: 36315912)
41. Identification of T-lymphocytic leukemia-initiating stem cells residing in a small subset of patients with acute myeloid leukemic disease.
Risueño RM; Campbell CJ; Dingwall S; Levadoux-Martin M; Leber B; Xenocostas A; Bhatia M
Blood; 2011 Jun; 117(26):7112-20. PubMed ID: 21562049
[TBL] [Abstract][Full Text] [Related]
42. Characterization of Imatinib Resistant CML Leukemic Stem/Initiating Cells and Their Sensitivity to CBP/Catenin Antagonists.
Zhao Y; Wu K; Wu Y; Melendez E; Smbatyan G; Massiello D; Kahn M
Curr Mol Pharmacol; 2018; 11(2):113-121. PubMed ID: 28933312
[TBL] [Abstract][Full Text] [Related]
43. Heterogeneous sensitivity of human acute myeloid leukemia to β-catenin down-modulation.
Gandillet A; Park S; Lassailly F; Griessinger E; Vargaftig J; Filby A; Lister TA; Bonnet D
Leukemia; 2011 May; 25(5):770-780. PubMed ID: 21339756
[TBL] [Abstract][Full Text] [Related]
44. The cellular senescence of leukemia-initiating cells from acute lymphoblastic leukemia is postponed by β-Arrestin1 binding with P300-Sp1 to regulate hTERT transcription.
Liu S; Liu H; Qin R; Shu Y; Liu Z; Zhang P; Duan C; Hong D; Yu J; Zou L
Cell Death Dis; 2017 Apr; 8(4):e2756. PubMed ID: 28425985
[TBL] [Abstract][Full Text] [Related]
45. CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphoblastic Leukemia.
Passaro D; Irigoyen M; Catherinet C; Gachet S; Da Costa De Jesus C; Lasgi C; Tran Quang C; Ghysdael J
Cancer Cell; 2015 Jun; 27(6):769-79. PubMed ID: 26058076
[TBL] [Abstract][Full Text] [Related]
46. MAPK/ERK2 phosphorylates ERG at serine 283 in leukemic cells and promotes stem cell signatures and cell proliferation.
Huang Y; Thoms JA; Tursky ML; Knezevic K; Beck D; Chandrakanthan V; Suryani S; Olivier J; Boulton A; Glaros EN; Thomas SR; Lock RB; MacKenzie KL; Bushweller JH; Wong JW; Pimanda JE
Leukemia; 2016 Jul; 30(7):1552-61. PubMed ID: 27055868
[TBL] [Abstract][Full Text] [Related]
47. γ-Catenin-Dependent Signals Maintain BCR-ABL1
Luong-Gardiol N; Siddiqui I; Pizzitola I; Jeevan-Raj B; Charmoy M; Huang Y; Irmisch A; Curtet S; Angelov GS; Danilo M; Juilland M; Bornhauser B; Thome M; Hantschel O; Chalandon Y; Cazzaniga G; Bourquin JP; Huelsken J; Held W
Cancer Cell; 2019 Apr; 35(4):649-663.e10. PubMed ID: 30991025
[TBL] [Abstract][Full Text] [Related]
48. Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemia.
Aoki Y; Watanabe T; Saito Y; Kuroki Y; Hijikata A; Takagi M; Tomizawa D; Eguchi M; Eguchi-Ishimae M; Kaneko A; Ono R; Sato K; Suzuki N; Fujiki S; Koh K; Ishii E; Shultz LD; Ohara O; Mizutani S; Ishikawa F
Blood; 2015 Feb; 125(6):967-80. PubMed ID: 25538041
[TBL] [Abstract][Full Text] [Related]
49. Normal or reactive minor cell populations in bone marrow and peripheral blood mimic minimal residual leukemia by flow cytometry.
Li W; Morgan R; Nieder R; Truong S; Habeebu SSM; Ahmed AA
Cytometry B Clin Cytom; 2021 Sep; 100(5):590-601. PubMed ID: 33197125
[TBL] [Abstract][Full Text] [Related]
50. Expression of beta-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis.
Ysebaert L; Chicanne G; Demur C; De Toni F; Prade-Houdellier N; Ruidavets JB; Mansat-De Mas V; Rigal-Huguet F; Laurent G; Payrastre B; Manenti S; Racaud-Sultan C
Leukemia; 2006 Jul; 20(7):1211-6. PubMed ID: 16688229
[TBL] [Abstract][Full Text] [Related]
51. FOXO3 gene polymorphisms influence the risk of acute lymphoblastic leukemia in Chinese children.
Yang X; Wu X; Fang N; Liu X; Liu X; Yang L; Huang K; Luo A; Cai M; Wu F; Jiang H; Xu L
J Cell Biochem; 2020 Feb; 121(2):2019-2026. PubMed ID: 31691337
[TBL] [Abstract][Full Text] [Related]
52. Therapy-resistant acute lymphoblastic leukemia (ALL) cells inactivate FOXO3 to escape apoptosis induction by TRAIL and Noxa.
Ausserlechner MJ; Salvador C; Deutschmann A; Bodner M; Viola G; Bortolozzi R; Basso G; Hagenbuchner J; Obexer P
Oncotarget; 2013 Jul; 4(7):995-1007. PubMed ID: 23828551
[TBL] [Abstract][Full Text] [Related]
53. Intra-heterogeneity in transcription and chemoresistant property of leukemia-initiating cells in murine Setd2
Song J; Du L; Liu P; Wang F; Zhang B; Xie Y; Lu J; Jin Y; Zhou Y; Lv G; Zhang J; Chen S; Chen Z; Sun X; Zhang Y; Huang Q
Cancer Commun (Lond); 2021 Sep; 41(9):867-888. PubMed ID: 34196511
[TBL] [Abstract][Full Text] [Related]
54. Eleven-marker 10-color flow cytometric assessment of measurable residual disease for T-cell acute lymphoblastic leukemia using an approach of exclusion.
Tembhare PR; Chatterjee G; Khanka T; Ghogale S; Badrinath Y; Deshpande N; Panda D; Patkar NV; Narula G; Girase K; Verma S; Sanyal M; Sriram HN; Banavali S; Gujral S; Subramanian PG
Cytometry B Clin Cytom; 2021 Jul; 100(4):421-433. PubMed ID: 32812702
[TBL] [Abstract][Full Text] [Related]
55. Expression of CD71 by flow cytometry in acute leukemias: More often seen in acute myeloid leukemia.
Pande A; Dorwal P; Jain D; Tyagi N; Mehra S; Sachdev R; Raina V
Indian J Pathol Microbiol; 2016; 59(3):310-3. PubMed ID: 27510666
[TBL] [Abstract][Full Text] [Related]
56. Optimal interleukin-7 receptor-mediated signaling, cell cycle progression and viability of T-cell acute lymphoblastic leukemia cells rely on casein kinase 2 activity.
Melão A; Spit M; Cardoso BA; Barata JT
Haematologica; 2016 Nov; 101(11):1368-1379. PubMed ID: 27470599
[TBL] [Abstract][Full Text] [Related]
57. Parthenolide eliminates leukemia-initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic leukemia.
Diamanti P; Cox CV; Moppett JP; Blair A
Blood; 2013 Feb; 121(8):1384-93. PubMed ID: 23264600
[TBL] [Abstract][Full Text] [Related]
58. Promotion of the self-renewal capacity of human acute leukemia cells by Wnt3A.
Kawaguchi-Ihara N; Murohashi I; Nara N; Tohda S
Anticancer Res; 2008; 28(5A):2701-4. PubMed ID: 19035298
[TBL] [Abstract][Full Text] [Related]
59. Regeneration-associated WNT signaling is activated in long-term reconstituting AC133bright acute myeloid leukemia cells.
Beghini A; Corlazzoli F; Del Giacco L; Re M; Lazzaroni F; Brioschi M; Valentini G; Ferrazzi F; Ghilardi A; Righi M; Turrini M; Mignardi M; Cesana C; Bronte V; Nilsson M; Morra E; Cairoli R
Neoplasia; 2012 Dec; 14(12):1236-48. PubMed ID: 23308055
[TBL] [Abstract][Full Text] [Related]
60. ZFX controls propagation and prevents differentiation of acute T-lymphoblastic and myeloid leukemia.
Weisberg SP; Smith-Raska MR; Esquilin JM; Zhang J; Arenzana TL; Lau CM; Churchill M; Pan H; Klinakis A; Dixon JE; Mirny LA; Mukherjee S; Reizis B
Cell Rep; 2014 Feb; 6(3):528-40. PubMed ID: 24485662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
